Parry, Aled http://orcid.org/0000-0001-5192-3727
Rulands, Steffen http://orcid.org/0000-0001-6398-1553
Reik, Wolf http://orcid.org/0000-0003-0216-9881
Article History
Accepted: 2 September 2020
First Online: 6 October 2020
Competing interests
: W.R. is a consultant and shareholder of Cambridge Epigenetix. The other authors declare no competing interests.